Effects of α-linolenic Acid Supplementation on Hemostasis in Nondiabetic and Hypercholesterolemic Subjects

Inclusion Criteria: * Voluntarily agree to participate and sign in informed consent form * Adults aged 40-70 * Nondiabetic and hypercholesterolemic subjects (serum cholesterol ≥ 200 mg/dL) Exclusion Criteria: * Subjects taking any medication or supplements known to affect lipid metabolism or platelet function, n-3 fatty acid supplementation or n-3 fatty acid-rich fish more than two times per week * Following diseases: dyslipidemia, hypertension, diabetes, liver disease, renal disease, pancreatitis, cardiovascular disease, gastrointestinal disease, cancer, or any other disease requiring treatment * Participation in clinical trials of any drug or supplement within 30 days prior to the participation of the study * Pregnant or lactating women, alcoholic, mental patient * Judged to be inappropriate for the study by the investigator after reviewing other reasons